Cargando…
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
Adjuvant tamoxifen treatment reduces the occurrence of contralateral breast cancer (CBC). The aim of the study was to investigate the hypothesis that adjuvant tamoxifen reduces the occurrence of oestrogen-receptor (ER)-positive CBC, but not the growth of ER-negative CBCs, and to examine survival aft...
Autores principales: | Kaas, R, Peterse, J L, Hart, A A M, Voogd, A C, Rutgers, E J T, van Leeuwen, F E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376344/ https://www.ncbi.nlm.nih.gov/pubmed/12618879 http://dx.doi.org/10.1038/sj.bjc.6600746 |
Ejemplares similares
-
Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
por: Murphy, L C, et al.
Publicado: (2002) -
Wild-type oestrogen receptor beta (ERβ1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
por: O'Neill, P A, et al.
Publicado: (2004) -
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers
por: Weigelt, B, et al.
Publicado: (2004) -
Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003) -
Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function
por: Bhat-Nakshatri, P, et al.
Publicado: (2004)